The 2022 Global Investment Summit was held on June 7, 2022, at the Shilla Hotel, Seoul. Minister of Trade, Industry and Energy, UNCTAD Head of Investment Research Richards Bolwijn, KOTRA CEO Yu Jeoung Yeol, Director of Investment Policy of MOTIE Jung Jong Yung, Partner of NLVC and Han River Partners Jeffrey D. Lee and Ericsson-LG CEO Hakan Cervell were among the speakers at the summit.
Shiftbio was also present at the event, where many startups from various fields across the country presented their business models by passing the initial elimination. Significantly, leading pharma and technology companies held one-on-one meetings with selected companies. Shiftbio team attended a confidential appointment with one of the major global pharma companies and presented its business model. The presentation attracted great attention having essential strategies and ideas for commercializing such a new drug modality, exosomes.
Shiftbio - LinkedIn https://kr.linkedin.com › company › shiftbio
The 2022 Global Investment Summit was held on June 7, 2022, at the Shilla Hotel, Seoul. Minister of Trade, Industry and Energy, UNCTAD Head of Investment Research Richards Bolwijn, KOTRA CEO Yu Jeoung Yeol, Director of Investment Policy of MOTIE Jung Jong Yung, Partner of NLVC and Han River Partners Jeffrey D. Lee and Ericsson-LG CEO Hakan Cervell were among the speakers at the summit.
Shiftbio was also present at the event, where many startups from various fields across the country presented their business models by passing the initial elimination. Significantly, leading pharma and technology companies held one-on-one meetings with selected companies. Shiftbio team attended a confidential appointment with one of the major global pharma companies and presented its business model. The presentation attracted great attention having essential strategies and ideas for commercializing such a new drug modality, exosomes.
Shiftbio - LinkedIn https://kr.linkedin.com › company › shiftbio